We believe that no matter which type of diabetes you have or treat it is important to understand how daily lifestyle choices impact future health and quality of life.
As with many startups, our direction has shifted since the company was founded in 2005. Six years of research and product development was followed by a refocus towards the market after Anders Weilandt took over as CEO.
Now our purpose is to combine apps (for smartphones and tablets), online accounts and web interfaces – the digital health toolbox – to change diabetes care for the better.
Founder and Chairman of the new business support group CIMON AB.
Member of the Rolf Luft Research Centre for Diabetes. Professor of Experimental Endocrinology at Karolinska Institutet in Stockholm. Professor Berggren is also a member of the Royal Swedish Academy of Sciences, Academia Europaea and the Nobel Assembly at Karolinska Institutet.
Director of the Center for Technology in Medicine and Health at Karolinska Institutet, Royal Institute of Technology (KTH) in Stockholm, Sweden. Also Associate Professor of Technology and Health at KTH and Head of Research Group for Clinical Innovation Research at KTH.
Business Development Manager for the Swedish design and innovation agency Screen Interaction AB.
Director of Biopolymer Products and Biopolymer Technology of Sweden AB.
Partner, Senior Corporate Finance and Business Development Advisor of Winpoint AB.
Chairman of AlphaBeta AB, BioCrine AB and Spiber Technologies AB. Also Board member of BioInvent International AB, Alligator Bioscience AB and Science Pacific AB.
The company’s certified public accountant is Johan Pharmanson from accountancy firm BDO.
To help us help you, please choose one fo the following options.
If you are adult patient looking for help with your Triabetes app, the online companion has a list
of frequently asked questions (FAQs). Sign in to get back on track.